Saint Luke's Newsroom

Saint Luke’s Cancer Institute Launches Innovative Digital Advocate for Advance Care Planning
Advance Care Appointment Companion is an intuitive digital advocate designed for patients to reflect on, create, and communicate their advance care plan with their care team and loved ones.
Healio: DARE-19: No significant decrease in major events; dapagliflozin well treated in COVID-19
Dr. Mikhail Kosiborod presented findings of the DARE-19 Trial at the ACC Scientific Session.
Thumbnail
Saint Luke’s Innovation Week Profile: Dr. Timothy Pluard
Dr. Timothy Pluard is a man on a mission. Growing up, Dr. Pluard always knew he wanted to be a doctor.
Saint Luke’s Innovation Week Profile: Dr. Mikhail Kosiborod
Growing up in a medical family, Dr. Mikhail Kosiborod knew he wanted to be a physician from a young age.
HCP Live: Heart Trials Podcast: DAPA-HF, with Mikhail Kosiborod, MD
Dr. Mikhail Kosiborod discusses the DAPA-HF trial, as well as the DARE-19 trial results, in this episode of HCP Live's Heart Trials podcast.
Medpage Today: Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy
Dr. John Spertus reported the health status analysis of the EXPLORER-HCM Trial at the ACC Scientific Session.
Healio: Marked health status improvement with mavacamten in obstructive hypertrophic cardiomyopathy
Dr. John Spertus presented new health status data from the EXPLORER-HCM Trial at the ACC Scientific Session.
DARE-19 Phase III trial did not reach statistical significance for primary endpoints, but showed numerically fewer events of new or worsened organ dysfunction or death in patients hospitalized with COVID-19
Saint Luke's Mid America Heart Institute shared detailed trial results in a Late Breaking Clinical Trials Session at the American College of Cardiology Scientific Session.
Saint Luke’s Researchers Again Take Center Stage at Global Cardiology Conference
Saint Luke’s Mid America Heart Institute to share detailed trial results at American College of Cardiology Scientific Session May 15-17.